.jpg)
.png)
All
Dr. Scott Kirkpatrick is SWLA’s 2022 Lipid Scholarship Program recipient, a PGY-5 cardiology fellow at the University of Arizona-Tuscon. As a future general cardiologist with a passion for preventive cardiology, his career mission is to help as many people as he can in the fight against... more
CLM-SAP 17 is a free CME online self-assessment program that will objectively validate and enhance your knowledge of the available clinical practice guidelines and recommendations related to lipid management in order to reduce atherosclerotic cardiovascular risk. As guidelines and recommendations... more
Discuss this article at www.lipid.org/lipidspin “I have never once dribbled the whole field and scored a goal by myself.” — Abby Wambach (retired US Women’s Soccer great) I am honored to have the unique opportunity to address LipidSpin readers as both its co-editor and guest editor (outgoing... more
The National Lipid Association provides meeting coverage and highlights for its members from select presentations at the American Heart Association's 2015 Annual Scientific Sessions in Orlando. Read our meeting coverage here. more
Patients of all ages and with all kinds of problems seek help in our busy family medicine clinic (10 providers, 33,000 visits a year), which is part of a four-clinic network of the Oregon Health & Science University (OHSU) Family Medicine Department. I work independently (although we do... more
Inclisiran (Leqvio; Novartis) is now the first small interfering RNA (siRNA) therapy to be approved by the FDA to reduce low-density lipoprotein cholesterol (LDL-C). Inclisiran was previously approved in the EU on 9 December 2020 for use in adults with primary hypercholesterolemia (heterozygous... more
Seven years ago, the Pacific Lipid Association’s (PLA’s) inaugural meeting took place on Jan. 18, 2007, at the Sheraton Hotel and Marina in San Diego. Recently, March 13–16, 2014, we jointly hosted the 2014 Spring Clinical Update (CLU): Atheroprevention: Global Perspectives and... more
This issue sponsored by the Midwest Lipid Association Featuring: "A National Lipid Association Best Practices Guide: PCSK9 Inhibitors"
Highlights from the NLA's Fall 2013 Clinical Lipid Update are now available on demand. You can now view selected presentations with audio from the sessions. Click here to view the highlights.